Company Filing History:
Years Active: 2017
Title: Innovations of Chongjun Liu in Pharmaceutical Chemistry
Introduction
Chongjun Liu is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of azetidinone compounds. With a total of three patents to his name, Liu's work has implications for drug formulation and therapeutic applications.
Latest Patents
One of Liu's latest patents focuses on the crystal forms of azetidinone compounds and their preparation methods. The invention provides crystal forms of the compound of (3R,4S)-4-(4-hydroxyphenyl)-3-[3-(4-fluorophenyl)-4-hydroxybut-2(Z)-enyl]-1-(4-fluorophenyl)-2-azetidinone (formula A). These crystal forms can be characterized by various analytical techniques, including X-ray powder diffraction (XRPD) spectra, differential scanning calorimetry (DSC) spectra, and infrared absorption spectra. Additionally, the patent outlines methods for preparing these crystal forms, along with their pharmaceutical compositions and potential uses.
Career Highlights
Chongjun Liu is currently associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is instrumental in advancing the understanding and application of azetidinone compounds in medicine.
Collaborations
Liu collaborates with several talented individuals in his field, including Hongyuan Wei and Xuyang Zhao. Their combined expertise contributes to the success of their research and development efforts.
Conclusion
Chongjun Liu's contributions to pharmaceutical chemistry, particularly through his patents on azetidinone compounds, highlight his role as an influential inventor in the industry. His ongoing work promises to enhance drug development and therapeutic options in the future.